Hölzenbein T J, Pomposelli F B, Miller A, Gibbons G W, Campbell D R, Freeman D V, LoGerfo F W
Harvard-Deaconess Surgical Service, New England Deaconess Hospital, Harvard Medical School, Boston, MA 02215, USA.
J Vasc Surg. 1995 Apr;21(4):586-92; discussion 592-4. doi: 10.1016/s0741-5214(95)70190-7.
The performance of a graft created from the upper arm basilic and cephalic veins in continuity was investigated.
Retrospective analysis of 50 patients, who underwent 54 distal reconstructions with an upper arm vein loop graft between February 1989 and October 1993 (male-to-female ratio of 30/20; mean age of 69.2 years, range 39 to 87; 74% had diabetes) was undertaken. Vein grafts were harvested through a near continuous incision, leaving a skin bridge in the cubita. Intraoperative angioscopy was used to exclude endoluminal disease and to directly observe valvulotomy of the nonreversed part of the graft.
Operations were performed for limb salvage in 98.2% of 17 primary and 37 reoperative procedures. Eleven femoropopliteal, 33 femorotibial-pedal, seven popliteal-distal, and two outflow jump grafts were performed. The ipsilateral saphenous vein was unavailable because of previous infrainguinal bypass in 35, coronary artery bypass grafting in 14, and unsuitable quality in 5 cases. Thirty-eight grafts were used in continuity, and 16 grafts required repair or splicing with additional vein segments. Primary 30-day patency rate was 92.6% (n = 4 occlusions). No operative deaths occurred. The cumulative patency rate at 1 year was 74.4%, the limb salvage rate 90.7%.
The upper arm vein loop is a durable graft with excellent short-term and midterm patency rates. Sufficient vein length can be obtained to reach the below-knee and midtibial levels. Angioscopic quality assessment is a valuable adjunct to exclude endoluminal disease most commonly occurring in the median cubital vein. Straightening the curve of the median cubital vein and valvulotomy do not influence patency rates. This is a valuable technique for vascular surgeons that enables rescue of ischemic limbs under otherwise difficult circumstances.
研究由上臂连续性的贵要静脉和头静脉构建的移植物的性能。
对1989年2月至1993年10月期间接受54例上臂静脉环移植物远端重建的50例患者进行回顾性分析(男30例,女20例;平均年龄69.2岁,范围39至87岁;74%患有糖尿病)。通过近乎连续的切口采集静脉移植物,在肘窝处保留皮肤桥。术中血管内镜用于排除腔内疾病并直接观察移植物非翻转部分的瓣膜切开术。
在17例初次手术和37例再次手术中,98.2%的手术是为了挽救肢体。进行了11例股腘动脉、33例股胫-足部、7例腘动脉-远端和2例流出道跳跃移植物手术。35例因先前的腹股沟下旁路手术、14例因冠状动脉旁路移植术以及5例因质量不合适而无法使用同侧大隐静脉。38例移植物连续使用,16例移植物需要用额外的静脉段进行修复或拼接。30天原发性通畅率为92.6%(4例闭塞)。无手术死亡发生。1年时的累积通畅率为74.4%,肢体挽救率为90.7%。
上臂静脉环是一种耐用的移植物,具有出色的短期和中期通畅率。可获得足够的静脉长度以到达膝下和胫骨中部水平。血管内镜质量评估是排除最常见于肘正中静脉的腔内疾病的有价值辅助手段。矫正肘正中静脉的弯曲和瓣膜切开术不影响通畅率。这是血管外科医生的一项有价值的技术,能够在其他困难情况下挽救缺血肢体。